Toggle Main Menu Toggle Search

Open Access padlockePrints

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomalformulation in patients with solid tumours

Lookup NU author(s): Professor Alastair GreystokeORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Evans TRJ, Dean E, Molife LR, Lopez J, Ranson M, El-Khouly F, Zubairi I, Savulsky C, Reyderman L, Jia Y, Sweeting L, Greystoke A, Barriuso J, Kristeleit R

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2019

Volume: 120

Issue: 4

Pages: 379–386

Print publication date: 01/02/2019

Online publication date: 25/01/2019

Acceptance date: 03/01/2019

Date deposited: 27/03/2019

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Nature Publishing Group

URL: https://doi.org/10.1038/s41416-019-0377-x

DOI: 10.1038/s41416-019-0377-x

PubMed id: 30679780


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
CR-UK A25174
Eisai
Experimental Cancer Medicine Centre (ECMC)
NIHR UCLH Biomedical Research Centre and Clinical Research Facility

Share